Cambridge Investment Research Advisors, Inc. Heron Therapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 27,867 shares of HRTX stock, worth $64,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,867
Previous 10,367
168.8%
Holding current value
$64,930
Previous $16,000
281.25%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding HRTX
# of Institutions
175Shares Held
115MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$62.2 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$19.8 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$19 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$16.3 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $277M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...